EAACI Congress 2025
BackJMA Poster session 04 - JMA Poster Session 4: Drug Allergy
Friday 13 Jun, 16:30 PM -
18:00 PM Glasgow, United Kingdom
Poster Zone
JMA
16:30
Association of chemokine levels with types of reactions after alcohol consumption in patients with nonsteroidal anti-inflammatory drugs exacerbated respiratory disease (N-ERD)
16:30
Delayed-Type Hypersensitivity to Omalizumab
16:30
Direct single dose mass delabelling of antibiotic allergy in paediatrics
16:30
Hypersensitivity reactions during therapy with platinum compounds and taxanes – who can benefit from consulting an allergist?
16:30
Impact of a Penicillin Allergy Delabeling Program on Antibiotic Selection and Perioperative Outcomes: A Prospective Comparative Cohort Study
16:30
Insights from Drug Provocation Testing in Quinolone Allergy
16:30
Iodinated Contrast Media During Acute DRESS: A Hidden Risk for Future Drug Hypersensitivity?
16:30
Nonsteroidal anti-inflammatory drug cross-hypersensitivity phenotypes show high carbonyl levels
16:30
Penicillin-allergic labelled patients with a PEN-FAST score of 0 could safely be de-labelled by non-allergists
16:30
Platinum salt hypersensitivity: Experience of our Center
16:30
SDRIFE related to generalized corticosteroids’ hypersensitivity: A case report
16:30
Sarcoid-like reaction induced by aspirin therapy after aspirin desensitization in a patient with aspirin-exacerbated respiratory disease
16:30
Synthetic folic acid allergy
16:30
The delabeling of beta-lactam allergy does not change the antibiotic prescribing profile or alerts in Primary Care. The experience of a General Hospital
